Target intelligence / Profile preview

Frizzled family Wnt receptor (FZD) (FZD)

Target
FZD
Molecular classification
G protein-coupled receptor, Receptor, Class F GPCR
01

Overview

Frizzled receptors are a family of ten distinct seven-transmembrane proteins (FZD1-10) that function as the principal receptors for secreted Wnt signaling ligands (UniProt, 2023). These receptors are classified as Class F G protein-coupled receptors and are essential for coordinating complex biological processes including embryonic development, cell fate determination, and tissue homeostasis (StatPearls, 2023). Upon Wnt binding, Frizzled receptors activate either the canonical beta-catenin pathway or non-canonical pathways like the planar cell polarity (PCP) and Wnt/Ca2+ pathways (PubMed, PMID: 28273102). Aberrant activation of Frizzled signaling is a hallmark of many cancers, where it drives uncontrolled cell proliferation and stemness, and is also linked to bone density and vascular diseases (Nature Reviews Drug Discovery, 2017). Therapeutic development targeting Frizzled receptors includes monoclonal antibodies like Vantictumab and decoy receptors like Ipafricept, though clinical progress has been tempered by safety concerns regarding bone health and intestinal integrity (Journal of Clinical Oncology, 2016).

Other names
FrizzledFrizzled-class G protein-coupled receptorsFZD receptorsFrizzled homolog
02

Mechanism of action

Antagonism of Wnt ligand binding to the extracellular cysteine-rich domain (CRD) of Frizzled receptors to inhibit downstream beta-catenin stabilization and TCF/LEF-mediated gene transcription (PubMed, PMID: 25135992).

03

Biological functions

Signal transductionCell proliferationCell differentiationEmbryonic developmentTissue homeostasisWnt signaling pathway
04

Disease associations

CancerOsteoporosisCardiovascular diseaseNeurodegenerative diseaseExudative vitreoperetinopathy
05

Safety considerations

Bone mineral density lossGastrointestinal toxicityImpaired tissue regenerationTeratogenicity
06

Interacting drugs

Vantictumab

3 more in the full profile.

07

Biomarkers

Beta-catenin nuclear localizationAXIN2 expressionWNT ligand levelsC-MYC expressionDvl2 phosphorylation

Beyond the preview

Go deeper on Frizzled family Wnt receptor (FZD) (FZD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Frizzled family Wnt receptor (FZD) (FZD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call